These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34585363)

  • 1. Post-COVID-vaccine autoimmune/inflammatory syndrome in response to adjuvants (ASIA syndrome) manifesting as subacute thyroiditis.
    Das L; Bhadada SK; Sood A
    J Endocrinol Invest; 2022 Feb; 45(2):465-467. PubMed ID: 34585363
    [No Abstract]   [Full Text] [Related]  

  • 2. Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome.
    İremli BG; Şendur SN; Ünlütürk U
    J Clin Endocrinol Metab; 2021 Aug; 106(9):2600-2605. PubMed ID: 34043800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions.
    Lee SW; Moon JY; Lee SK; Lee H; Moon S; Chung SJ; Yeo Y; Park TS; Park DW; Kim TH; Sohn JW; Yoon HJ; Kim SH
    Front Immunol; 2021; 12():779212. PubMed ID: 34899739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Variant of Guillain-Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine.
    Badoiu A; Moranne O; Coudray S; Ion IM
    J Clin Neuromuscul Dis; 2021 Dec; 23(2):115-116. PubMed ID: 34808658
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management.
    Caron P
    Endocrine; 2022 Dec; 78(3):406-417. PubMed ID: 35763241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent thyroiditis following vaccination against COVID-19: report of two cases.
    Capezzone M; Tosti-Balducci M; Morabito EM; Caldarelli GP; Sagnella A; Cantara S; Alessandri M; Castagna MG
    J Endocrinol Invest; 2022 May; 45(5):1079-1083. PubMed ID: 35034341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19.
    Lui DTW; Lee CH; Chow WS; Lee ACH; Tam AR; Fong CHY; Law CY; Leung EKH; To KKW; Tan KCB; Woo YC; Lam CW; Hung IFN; Lam KSL
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e926-e935. PubMed ID: 33141191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
    PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves' disease to silent thyroiditis.
    Pujol A; Gómez LA; Gallegos C; Nicolau J; Sanchís P; González-Freire M; López-González ÁA; Dotres K; Masmiquel L
    J Endocrinol Invest; 2022 Apr; 45(4):875-882. PubMed ID: 34792795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
    Speer G; Somogyi P
    Endocr J; 2021 Feb; 68(2):129-136. PubMed ID: 33473054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
    Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus Disease-2019 (COVID-19) Vaccination.
    Hasegawa T; Yazaki Y
    Circ J; 2022 Mar; 86(4):723. PubMed ID: 34840204
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity and efficacy of          heterologous ChAdOx1-BNT162b2 vaccination.
    Pozzetto B; Legros V; Djebali S; Barateau V; Guibert N; Villard M; Peyrot L; Allatif O; Fassier JB; Massardier-Pilonchéry A; Brengel-Pesce K; Yaugel-Novoa M; Denolly S; Boson B; Bourlet T; Bal A; Valette M; Andrieu T; Lina B; ; Cosset FL; Paul S; Defrance T; Marvel J; Walzer T; Trouillet-Assant S
    Nature; 2021 Dec; 600(7890):701-706. PubMed ID: 34673755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome.
    Ling L; Bagshaw SM; Villeneuve PM
    CMAJ; 2021 Nov; 193(46):E1766-E1769. PubMed ID: 34810163
    [No Abstract]   [Full Text] [Related]  

  • 15. Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity.
    Chakraborty U; Ghosh S; Chandra A; Ray AK
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 timeline of events.
    Webster P
    Nat Med; 2021 Dec; 27(12):2054-2055. PubMed ID: 34907389
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
    Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
    Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
    Groß R; Zanoni M; Seidel A; Conzelmann C; Gilg A; Krnavek D; Erdemci-Evin S; Mayer B; Hoffmann M; Pöhlmann S; Liu W; Hahn BH; Beil A; Kroschel J; Jahrsdörfer B; Schrezenmeier H; Kirchhoff F; Münch J; Müller JA
    EBioMedicine; 2022 Jan; 75():103761. PubMed ID: 34929493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Roberge G; Carrier M
    Clin Appl Thromb Hemost; 2022; 28():10760296221086283. PubMed ID: 35275495
    [No Abstract]   [Full Text] [Related]  

  • 20. Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2.
    Plüß M; Mese K; Kowallick JT; Schuster A; Tampe D; Tampe B
    Front Immunol; 2021; 12():784145. PubMed ID: 35116025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.